Envarsus XR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Veloxis Pharmaceuticals, Inc. The primary component is Tacrolimus.
Product ID | 68992-3075_123aa480-0d98-46dc-8c45-7f528c6d3a06 |
NDC | 68992-3075 |
Product Type | Human Prescription Drug |
Proprietary Name | Envarsus XR |
Generic Name | Tacrolimus |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2015-09-01 |
Marketing Category | NDA / NDA |
Application Number | NDA206406 |
Labeler Name | Veloxis Pharmaceuticals, Inc |
Substance Name | TACROLIMUS |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-09-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206406 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-01 |
Marketing Category | NDA |
Application Number | NDA206406 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-09-01 |
Ingredient | Strength |
---|---|
TACROLIMUS | .75 mg/1 |
SPL SET ID: | de2315b0-6344-43ac-9aea-3e3b68d828e7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
68992-3010 | Envarsus XR | Envarsus XR |
68992-3075 | Envarsus XR | Envarsus XR |
68992-3040 | Envarsus XR | Envarsus XR |
0469-0607 | Prograf | Tacrolimus |
0469-0617 | Prograf | Tacrolimus |
0469-0657 | Prograf | Tacrolimus |
0093-3428 | Tacrolimus | tacrolimus |
0093-3429 | Tacrolimus | tacrolimus |
0168-0416 | Tacrolimus | tacrolimus |
0168-0417 | Tacrolimus | tacrolimus |
0378-2045 | Tacrolimus | Tacrolimus |
0378-2046 | Tacrolimus | Tacrolimus |
0378-2047 | Tacrolimus | Tacrolimus |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ENVARSUS 79133181 4457206 Live/Registered |
Veloxis Pharmaceuticals A/S 2013-02-07 |